Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin-2 nephrotoxicity assessed in vitro.

T J Hall1, P R James, G Cambridge

  • 1MD Laboratories, Congleton, Cheshire, U.K.

Research Communications in Chemical Pathology and Pharmacology
|September 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Constraint on Atmospheric Millicharged Particles with the LUX-ZEPLIN Experiment.

Physical review letters·2025
Same author

Dark Matter Search Results from 4.2  Tonne-Years of Exposure of the LUX-ZEPLIN (LZ) Experiment.

Physical review letters·2025
Same author

Correlation length ratio as a parameter for determination of fiber-like structures in soft tissues.

Physics in medicine and biology·2021
Same author

B cell phenotypes in patients with rheumatoid arthritis relapsing after rituximab: expression of B cell-activating factor-binding receptors on B cell subsets.

Clinical and experimental immunology·2017
Same author

SEA URCHIN DNA SEQUENCE VARIATION AND REDUCED INTERSPECIES DIFFERENCES OF THE LESS VARIABLE DNA SEQUENCES.

Evolution; international journal of organic evolution·2017
Same author

Comparative genomic identification and validation of β-defensin genes in the Ovis aries genome.

BMC genomics·2017

Interleukin-2 (IL-2) immunotherapy causes kidney damage. This study found human recombinant IL-2 (HrIL-2) directly harms kidney cells, independent of tumor necrosis factor-alpha (TNF-a).

Area of Science:

  • Nephrology
  • Immunology
  • Cell Biology

Background:

  • Interleukin-2 (IL-2) immunotherapy is a cancer treatment.
  • Nephrotoxicity is a significant limiting side effect of IL-2 therapy.
  • Tumor necrosis factor-alpha (TNF-a) mediates some IL-2 side effects.

Purpose of the Study:

  • To investigate the in vitro mechanisms of IL-2-induced nephrotoxicity.
  • To determine if TNF-a mediates IL-2 nephrotoxicity in a kidney cell model.
  • To assess the direct effect of IL-2 on kidney cells.

Main Methods:

  • Utilized the pig kidney cell line LLC-PK.1 for in vitro studies.
  • Exposed LLC-PK.1 cells to human recombinant IL-2 (HrIL-2).
  • Assessed the impact of dexamethasone and TNF-a on IL-2 toxicity.

Related Experiment Videos

Main Results:

  • HrIL-2 demonstrated toxicity to LLC-PK.1 cells at clinically relevant concentrations.
  • Dexamethasone did not mitigate HrIL-2-induced nephrotoxicity in vitro.
  • LLC-PK.1 cells were resistant to the anti-proliferative effects of TNF-a.

Conclusions:

  • IL-2 nephrotoxicity may result from a direct toxic effect on kidney cells.
  • The mechanism of IL-2 nephrotoxicity in this model is independent of TNF-a.
  • Findings suggest novel therapeutic strategies targeting direct kidney cell protection.